TYP 0.00% 4.9¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    The lack of patience or understanding about how deals work in the bio space is breathtaking. The company has been completely thwarted by the covid restrictions given their proprietary set up here in Melbourne . No one could come here . These things always take longer than anyone thinks anyway.

    If Dixon says Ex1 is in discussions with potential partners that's what's happening.

    2 or 3 years isn't very long in this sector. Have a look at the charts of any bio that's had success in the country or even elsewhere. It's a rough ride.

    I couldn't care less what the market does. This will be a successful company. In whatever time it takes to become one . Everybody including myself got a little ahead of ourselves but it doesn't lessen my confidence in what they are achieving and what the ultimate outcome will be.

    But for those who don't see it that way just move on. There's plenty of other bios out there doing a lot worse than this one if you want to put your money there.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.000(0.00%)
Mkt cap ! $60.10M
Open High Low Value Volume
5.0¢ 5.1¢ 4.6¢ $297.0K 6.063M

Buyers (Bids)

No. Vol. Price($)
1 12000 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 249224 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.